Jakstaite, Aldona <br/><br/>
HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.  [electronic resource] 

 -  World journal of gastroenterology  Dec 2015 
 - 13004-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2219-2840 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v21.i46.13004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Pancreatic Ductal--genetics<br/>Caspase 3--metabolism<br/>Caspase 7--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Combined Modality Therapy<br/>Cyclooxygenase 2--genetics<br/>Deoxycytidine--analogs & derivatives<br/>Drug Resistance, Neoplasm<br/>ELAV-Like Protein 1--genetics<br/>Enzyme Activation<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Neoplastic<br/>Heme Oxygenase-1--genetics<br/>Humans<br/>Pancreatic Neoplasms--genetics<br/>RNA Interference<br/>RNA Processing, Post-Transcriptional<br/>Transfection<br/>Gemcitabine